$PLRX
Pliant Therapeutics Inc
PRICE
$14.15 βΌ-0.212%
Delayed Price
VOLUME
165,872
DAY RANGE
- 14.25
52 WEEK
12.61 - 36.64
Key Metrics
Market Cap
849.32 M
Beta
0.80
Avg. Volume
454.14 K
Shares Outstanding
59.90 M
Yield
0%
Public Float
0
Next Earnings Date
2024-03-07
Next Dividend Date
Company Information
pliant therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases. by harnessing the therapeutic potential of integrin biology and tgf-Ξ² modulation, pliant aims to prevent or even reverse fibrosis to address the needs of many patients. the company also aims to build a patient registry for certain areas of fibrotic disease to both increase understanding of natural disease progression, and fuel biomarker discovery. pliantβs co-founders include world-renowned researchers from university of california, san francisco (ucsf), who bring broad experience in fibrosis biology and small molecule chemistry. together, the pliant team is dedicated to translating scientific advances in fibrosis biology into novel therapies for patients in need.
CEO: Bernard Coulie
Website: https://pliantrx.com/
HQ: 260 Littlefield Avenue South San Francisco, 94080 California
Related News